國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Rare diseases." ]

切換: 標籤 | MARC模式 | ISBD

Identifying novel inborn errors of t...

Salzer, Elisabeth.

Identifying novel inborn errors of the immune systemprimary immunodeficiencies with defective class switch and autoimmunity /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Identifying novel inborn errors of the immune systemby Elisabeth Salzer.
其他題名:	primary immunodeficiencies with defective class switch and autoimmunity /
作者:	Salzer, Elisabeth.
出版者:	Wiesbaden :Springer Fachmedien Wiesbaden :2017.
面頁冊數:	xxiii, 76 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Immunologic diseasesGenetic aspects.
電子資源:	http://dx.doi.org/10.1007/978-3-658-16796-7
ISBN:	9783658167967$q(electronic bk.)

Identifying novel inborn errors of the immune systemprimary immunodeficiencies with defective class switch and autoimmunity /
Salzer, Elisabeth.

Identifying novel inborn errors of the immune systemprimary immunodeficiencies with defective class switch and autoimmunity /[electronic resource] :by Elisabeth Salzer. - Wiesbaden :Springer Fachmedien Wiesbaden :2017. - xxiii, 76 p. :ill., digital ;24 cm. - BestMedDiss. - BestMedDiss..

CD27 Deficiency-Description of a Large Patient Cohort -- PRKCD Deficiency with Lupus-Like Autoimmunity -- IL-21 Deficiency Results in Very Early-Onset Inflammatory Bowel Disease.

In her study Elisabeth Salzer describes three novel monogenic diseases. For CD27 deficiency Elisabeth Salzer describes a large cohort of patients. Although all patients shared the same causative missense mutation, they displayed diverse clinical presentations. In another patient she was able to identify a mutation in PRKCD resulting in a primary immunodeficiency with severe Lupus-like autoimmunity. The patient exhibited increased mRNA levels of IL6. Therefore, treatment with Tocilizumab, a humanized anti-IL-6 receptor monoclonal antibody was suggested. In a family with a history of deaths due to inflammatory bowel disease she identified a missense mutation in IL21. She produced wild type and mutated IL-21 protein and demonstrated a loss of function phenotype. As IL-21 is in clinical trials, she proposed a potentially curative treatment option. These discoveries contributed to the understanding of the multifaceted regulatory mechanisms of the immune system and highlighted essential players in these complex signaling networks. Contents CD27 Deficiency-Description of a Large Patient Cohort PRKCD Deficiency with Lupus-Like Autoimmunity IL-21 Deficiency Results in Very Early-Onset Inflammatory Bowel Disease Target Groups Scientists and students in the field of pediatrics, immunology, gastroenterology, rheumatology and genetics Pediatricians About the Author Dr. Elisabeth Salzer works on the discovery and description of novel immunodeficiencies in children and adolescents at the CeMM Center for Molecular Medicine.

ISBN: 9783658167967$q(electronic bk.)

Standard No.: 10.1007/978-3-658-16796-7doiSubjects--Topical Terms:

773278
Immunologic diseases
--Genetic aspects.

LC Class. No.: RC582

Dewey Class. No.: 616.97042

Identifying novel inborn errors of the immune systemprimary immunodeficiencies with defective class switch and autoimmunity /
LDR:02736nmm a2200325 a 4500 001 506944
003 DE-He213
005 20170816120255.0
006 m d
007 cr nn 008maaau
008 171030s2017 gw s 0 eng d
020 $a 9783658167967$q(electronic bk.)
020 $a 9783658167950$q(paper)
024 7 $a 10.1007/978-3-658-16796-7 $2 doi
035 $a 978-3-658-16796-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC582
072 7 $a MJW $2 bicssc
072 7 $a MED069000 $2 bisacsh
082 0 4 $a 616.97042 $2 23
090 $a RC582 $b .S186 2017
100 1 $a Salzer, Elisabeth. $3 773277
245 1 0 $a Identifying novel inborn errors of the immune system $h [electronic resource] : $b primary immunodeficiencies with defective class switch and autoimmunity / $c by Elisabeth Salzer.
260 $a Wiesbaden : $b Springer Fachmedien Wiesbaden : $b Imprint: Springer, $c 2017.
300 $a xxiii, 76 p. : $b ill., digital ; $c 24 cm.
490 1 $a BestMedDiss
505 0 $a CD27 Deficiency-Description of a Large Patient Cohort -- PRKCD Deficiency with Lupus-Like Autoimmunity -- IL-21 Deficiency Results in Very Early-Onset Inflammatory Bowel Disease.
520 $a In her study Elisabeth Salzer describes three novel monogenic diseases. For CD27 deficiency Elisabeth Salzer describes a large cohort of patients. Although all patients shared the same causative missense mutation, they displayed diverse clinical presentations. In another patient she was able to identify a mutation in PRKCD resulting in a primary immunodeficiency with severe Lupus-like autoimmunity. The patient exhibited increased mRNA levels of IL6. Therefore, treatment with Tocilizumab, a humanized anti-IL-6 receptor monoclonal antibody was suggested. In a family with a history of deaths due to inflammatory bowel disease she identified a missense mutation in IL21. She produced wild type and mutated IL-21 protein and demonstrated a loss of function phenotype. As IL-21 is in clinical trials, she proposed a potentially curative treatment option. These discoveries contributed to the understanding of the multifaceted regulatory mechanisms of the immune system and highlighted essential players in these complex signaling networks. Contents CD27 Deficiency-Description of a Large Patient Cohort PRKCD Deficiency with Lupus-Like Autoimmunity IL-21 Deficiency Results in Very Early-Onset Inflammatory Bowel Disease Target Groups Scientists and students in the field of pediatrics, immunology, gastroenterology, rheumatology and genetics Pediatricians About the Author Dr. Elisabeth Salzer works on the discovery and description of novel immunodeficiencies in children and adolescents at the CeMM Center for Molecular Medicine.
650 0 $a Immunologic diseases $x Genetic aspects. $3 773278
650 0 $a Rare diseases. $3 491932
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Pediatrics. $3 274247
650 2 4 $a Immunology. $3 189152
650 2 4 $a Human Genetics. $3 273658
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a BestMedDiss. $3 738226
856 4 0 $u http://dx.doi.org/10.1007/978-3-658-16796-7
950 $a Medicine (Springer-11650)